Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-04-11
1999-01-12
Scheiner, Toni R.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303873, 5303882, 53038824, 53038885, 5303891, 5303892, 5303911, 5303913, 4241391, 4241411, C07K 1618, A61K 39395
Patent
active
058592067
ABSTRACT:
Novel polypeptides with binding affinity for the p185.sup.HER2 receptor, designated heregulin 2-.alpha. and heregulin 2-.beta., have been identified and purified from human tissue. The cDNA encoding the novel heregulin 2-.alpha. has been isolated from human tissue and sequenced. Provided herein is nucleic acid sequence of the heregulin 2-.alpha. useful in the production of heregulin 2-.alpha. by recombinant means. Further provided an amino acid sequence of heregulin 2-.alpha. and heregulin 2-.beta.. Heregulins and their antibodies are useful as therapeutic agents and in diagnostic methods.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4816567 (1989-03-01), Cabilly
patent: 4882275 (1989-11-01), Klagsburn
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5169837 (1992-12-01), Lagarde et al.
patent: 5237056 (1993-08-01), Fischbach
patent: 5367060 (1994-11-01), Vandlen et al.
patent: 5464751 (1995-11-01), Greene et al.
patent: 5578482 (1996-11-01), Lippman et al.
patent: 5594114 (1997-01-01), Goodearl et al.
patent: 5641869 (1997-06-01), Vandlen et al.
Davis et al., "Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned medium" Biochem. & Biophys. Res. Comm. 179(3):1536-1542 (1991).
Dobashi et al., "Characterization and Sequence Analysis of the Human Ornithine Decarboxylase Gene" DNA 8(9):623-634 (1989).
Fitzgerald et al., "Characterization and Sequence Analysis of the Human Ornithine Decarboxylase Gene" DNA 8(9):623-634 (1989).
Hoffman, Michelle, "New Clue Found to Oncogene's Role in Breast Cancer" Science 256:1129 (1992).
Holmes et al., "Identification of heregulin, a specific activator of p185.sup.erbB2 " Science 256:1205-1210 (1992).
Kunisada et al., "Sequence Organization of Repetitive Sequence Enriched in Small Polydisperse Circular DNA's from HeLa Cells" J. Mol. Biol. 198:557-565 (1987).
Lupu et al., "Purification of a novel growth factor that binds exclusively to the erbB-2 receptor protein and induces cellular respones" Proc. Am. Assoc. Cancer Res. 32:abst. No. 297, p. 50 (1991).
Marchionni et al., "Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system" Nature 362:312-318 (1993).
Peles et al., "Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glycoprotein That Induces Differentiation of Mammary Tumor Cells" Cell 69(1): 205-216 (1992).
Pohlenz et al., "The Human VK Locus, Charactization of Extended Immunoglobulin Gene Regions by Cosmid Cloning" J. Mol. Biol. 193:241-253 (1987).
Tarakhovsky et al., "A 25 kDa polypeptide is the ligand for p185Neu and is secreted by activated macrophages" Oncogene 6(12):2187-2196 (1991).
Wen et al., "Neu differentiation factor: a transmembrane glycoprotein containing an EGF Domain and an Immunoglobulin Homology Unit" Cell 69(3):559-572 (1992).
Xu et al. Eighty-Second Annual Meeting of the American Association for Cancer Research Proceedings 32:260 (Abstract No. 1544 1991).
Yarden, "Biochemical Analysis of the Ligand for the neu Oncogenic Receptor" Biochemistry 30:3543-3550 (1991).
Groenen et al., "Structure-function relationships for the EGF/TGF-alpha family of mitogens" Growth Factors 11:235-237 (1994).
Benveniste et al., "Purification and characterization of a human T-lymphocyte-derived glial growth-promoting factor" Proc. Natl. Acad. Sci. 82:3930-3934 (1985).
Brockes, "Assay and isolation of glial growth factor from the bovine pituitary" Methods in Enzymology 147:217-225 (1987).
Brockes et al., "Glial growth factor-like activity in Schwann Cell tumors" Annals of Neurology 20:317-322 (1986).
Brockes et al., "Purification and preliminary characterization of a glial growth factor from the bovine pituitary" Journal of Biological Chemistry 255(18):8374-8377 (1980).
Davis et al., "Platelet-derived growth factors and fibroblast growth are mitogens for rat Schwann Cells" Journal of Cell Biology 110:1353-1360 (1990).
De Corte et al., "A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells" J. Cell Science 107:405-416 (1994).
Falls et al., "ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family" Cell 72:801-815 (1993).
Gray et al., "Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor" Nature 303:722-725 (1983).
Kimura et al., "Structure, expression and function of schwannoma-derived growth factor" Nature 348:257-260 (1990).
Kokai et al., "Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products" Proc. Natl. Acad. Sci USA 85:5389-5393 (1988).
Lemke & Brockes, "Identification and purification of glial growth factor" J. Neurosci. 4(1):75-83 (1984).
Lupu et al., "Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185.sup.erbB2 " Science 249:1552-1555 (1990).
Lupu et al., "Purification and Characterization of a Novel Growth Factor from Human Breast Cancer Cells" Biochemistry 31:7330-7340 (1992).
Sliwkowski et al., "Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin" Journal of Biological Chemistry 269(20):14661-14665(1994).
Yarden et al., "Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene" Proc. Natl. Acad. Sci. USA 86:3179-3183 (1989).
Lupu and Lippman, Breast Cancer Res. Treat. 27(1-2) 83-93, 1993.
Holmes William E.
Vandlen Richard L.
Genentech Inc.
Johnson Nancy A.
Lee Wendy M.
Scheiner Toni R.
LandOfFree
Antibodies specific for heregulin 2-.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies specific for heregulin 2-.alpha., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies specific for heregulin 2-.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1517661